A role for ASXL1 as a tumor suppressor was suggested by the altered gene expression by Asxl1 deletion and the upregulation of genes involved in cell-cycle progression (e.g., E2F1 target genes such as Nmyc). The gene discussed is MYCN; the disease is neoplasm.